The Role of Imaging in Hepatocellular Carcinoma
- 1 July 2013
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Clinical Gastroenterology
- Vol. 47 (Supplement), S7-S10
- https://doi.org/10.1097/mcg.0b013e31827f0d3d
Abstract
Imaging plays an important role in diagnosis and management of patients with hepatocellular carcinoma (HCC). Although ultrasound is the main surveillance imaging tool for HCC, dynamic contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) are used primarily for diagnosis and staging of HCC. Recent advances in both CT and MRI technology have led to a decrease in ionizing radiation exposure and improved capabilities for evaluation of HCC, including, dynamic contrast-enhanced CT and MRI, perfusion CT and MRI, dual-energy CT, radiation dose reduction strategies, diffusion-weighted imaging, MR elastography, iron and fat quantification, and intravenous hepatobiliary contrast agents.Keywords
This publication has 31 references indexed in Scilit:
- Hepatocellular CarcinomaNew England Journal of Medicine, 2011
- Management of hepatocellular carcinoma: An updateHepatology, 2011
- Modern Approach to Hepatocellular CarcinomaCurrent Gastroenterology Reports, 2010
- Dual-energy-CT of hypervascular liver lesions in patients with HCC: investigation of image quality and sensitivityEuropean Radiology, 2010
- First performance evaluation of a dual-source CT (DSCT) systemEuropean Radiology, 2005
- Management of hepatocellular carcinomaHepatology, 2005
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Perfusion Imaging of the Liver: Current Challenges and Future GoalsRadiology, 2005
- Estimating the world cancer burden: Globocan 2000International Journal of Cancer, 2001
- Functional images of hepatic perfusion obtained with dynamic CT.Radiology, 1993